Showing results (291-300 of 433) with videos related to
Sort By:
Pageof 44
Clinical Drug Investigation|March 29, 2008
Efficacy and tolerability of amlodipine in the general practice treatment of essential hypertension in an asian multinational populationS H Taylor, M F Chen, S J Lee, et al.Leukemia|November 25, 2010
HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cellsW Song, Y-T Tai, Z Tian, et al.Journal of Immunological Methods|February 17, 2000
Isolation and characterization of human multiple myeloma cell enriched populationsY T Tai, G Teoh, Y Shima, et al.Journal of Thrombosis and Haemostasis : JTH|December 30, 2015
Interleukin-10 does not modulate clopidogrel platelet response in miceQ Yin, T Tai, J-Z Ji, et al.Neuro-Oncology|September 12, 2001
Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumorsT C Comas, T Tai, D Kimmel, et al.The American Journal of Cardiology|May 1, 1996
Spectrum of electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart diseaseK L Lee, M R Lauer, C Young, et al.The Journal of Biological Chemistry|September 7, 2000
Large scale gene expression analysis of cholesterol-loaded macrophagesD Shiffman, T Mikita, J T Tai, et al.Leukemia|July 29, 2017
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivoS Hipp, Y-T Tai, D Blanset, et al.Biochemical and Biophysical Research Communications|February 23, 2010
Protective effects of methyl gallate on H2O2-induced apoptosis in PC12 cellsJames A G Crispo, Matthew Piché, Dominique R Ansell, et al.Leukemia|December 28, 2016
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivoS Hipp, Y-T Tai, D Blanset, et al.Pageof 44